Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning.
Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis.
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.
Trial watch: Chemotherapy with immunogenic cell death inducers.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
DMDs Are an Essential Issue But Are They the Only Issue in MS Treatment?
FDA approves clinical trial of TDI-132 (Gilenya) in ALS patients
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases.
[Chronic cerebrospinal venous insufficiency--pathophysiology and treament].
Dual role of Response gene to complement-32 in multiple sclerosis.
Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment.
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
Microparticle Platform
An evidence-based review of natalizumab therapy in the management of Crohn's disease.
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.
Keeping cool: use of air conditioning by australians with multiple sclerosis.
Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients.
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets.
Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.
Simvastatin: two decades in a circle.
[Symptoms of circadian desynchronization in patients with multiple sclerosis.]
The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.
Venocentric Lesions: An MRI Marker of MS?

Pages